Bausch & Lomb
This article was originally published in The Tan Sheet
Executive Summary
Sales from continuing businesses for the fiscal fourth quarter ended Dec. 25 totaled $466.6 mil., up 8.9%. Excluding foreign exchange rates, sales increased 11% over the prior-year period. After restructuring charges and the results of discontinued operations, net income for the quarter was $17.2 mil. For the year, sales rose 9.9% to $1.76 bil. Factoring in restructuring charges, a gain on redemption of securities in the third quarter and purchase accounting adjustments and write-offs from 1998, net income reached $444.8 mil. for the year. Bausch & Lomb vision care revenues rose 6% for the quarter, while pharmaceutical sales rose 12%. Domestic sales accounted for 51% of total revenues and jumped 11% in the quarter